Search Results - "Villano, Carlo"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Imaging of Brain Tumors with Copper-64 Chloride: Early Experience and Results by Panichelli, Paola, Villano, Carlo, Cistaro, Angelina, Bruno, Andrea, Barbato, Francesco, Piccardo, Arnoldo, Duatti, Adriano

    Published in Cancer biotherapy & radiopharmaceuticals (01-06-2016)
    “…To conduct the first investigational study that is aimed at evaluating the ability of the simple salt (64)CuCl2 to diagnose cerebral tumors in patients…”
    Get more information
    Journal Article
  2. 2

    Efficacy and Safety of the 64Cu(II)Cl2 PET/CT for Urological Malignancies: Phase IIa Clinical Study by Mascia, Manlio, Villano, Carlo, De Francesco, Valerio, Schips, Luigi, Marchioni, Michele, Cindolo, Luca

    Published in Clinical nuclear medicine (01-06-2021)
    “…The aim of this study was to evaluate safety and efficacy of copper-64(II)dichloride (64Cu(II)Cl2) as a new PET tracer for urological malignancies (UMs)…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Atypical Presentation of COVID-19 Incidentally Detected at 18F-FDG PET/CT in an Asymptomatic Oncological Patient by Mattoli, Maria Vittoria, Taralli, Silvia, Pennese, Elsa, D’Angelo, Carla, Angrilli, Francesco, Villano, Carlo

    Published in Clinical nuclear medicine (01-08-2020)
    “…ABSTRACTThe incidence of COVID-19, a severe acute respiratory syndrome caused by SARS-CoV-2, is rapidly growing worldwide. In this pandemic period, the chance…”
    Get full text
    Journal Article
  5. 5

    Copper-64 Dichloride as Theranostic Agent for Glioblastoma Multiforme: A Preclinical Study by Rubini, Giuseppe, Coccetti, Daniela, Giacobbi, Beatrice, Villano, Carlo, Niccoli Asabella, Artor, Ferrari, Cristina, Panichelli, Paola

    Published in BioMed research international (01-01-2015)
    “…Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults with a median survival time less than one year. To date, there are…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours by Savelli, Giordano, Lucignani, Giovanni, Seregni, Ettore, Marchianò, Alfonso, Serafini, Gianluca, Aliberti, Gianluca, Villano, Carlo, Maccauro, Marco, Bombardieri, Emilio

    Published in Nuclear medicine communications (01-05-2004)
    “…The aim of this study was to assess the feasibility of somatostatin receptor scintigraphy (SRS) for the detection of the site of unknown primary neuroendocrine…”
    Get full text
    Journal Article
  8. 8

    Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer by Maccauro, Marco, Lucignani, Giovanni, Aliberti, Gianluca, Villano, Carlo, Castellani, Maria Rita, Solima, Eugenio, Bombardieri, Emilio

    “…The purpose of this study was to assess the feasibility of sentinel lymph node (SLN) detection in endometrial cancer patients with a dual-tracer procedure…”
    Get full text
    Journal Article
  9. 9

    Recombinant human thyrotropin (rhTSH) in the follow-up and treatment of patients with thyroid cancer by Bombardieri, Emilio, Seregni, Ettore, Villano, Carlo, Aliberti, Gianluca, Mattavelli, Franco

    Published in Tumori (01-09-2003)
    “…The follow-up of thyroid cancer is based on the detection of residual and recurrent thyroid carcinoma. This is traditionally done by means of measurements of…”
    Get full text
    Journal Article
  10. 10

    Critical aspects of immunoradiometric thyroglobulin assays by Ferrari, Leonardo, Biancolini, Donatella, Seregni, Ettore, Aliberti, Gianluca, Martinetti, Antonia, Villano, Carlo, Pallotti, Federica, Chiesa, Carlo, Bombardieri, Emilio

    Published in Tumori (01-09-2003)
    “…Thyroglobulin (Tg) evaluation is currently used in the follow-up of patients with differentiated thyroid carcinoma (DTC), but the measurement methods are…”
    Get full text
    Journal Article
  11. 11

    Diagnostic procedures in the follow-up of patients affected by MEN type 2 by Seregni, Ettore, Pallotti, Federica, Mattavelli, Franco, Ferrari, Leonardo, Martinetti, Antonia, Aliberti, Gianluca, Villano, Carlo, Castellani, Maria Rita, Bombardieri, Emilio

    Published in Tumori (01-09-2003)
    “…Multiple endocrine neoplasia type 2 (MEN 2) is an inherited disease caused by germline mutations in the RET proto-oncogene. The most distinctive MEN 2 variants…”
    Get full text
    Journal Article